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Wnt/β-cateninbe essential for normal pituitary development. The homeobox gene Six3 is
expressed in the developing pituitary gland during mouse development but its function in this tissue has
been precluded by the fact that in the Six3-deﬁcient embryos the pituitary gland is not induced. To gain
insights into the function of Six3 during pituitary development we have generated Six3+/−;Hesx1Cre/+ double
heterozygous mice. Strikingly, these mice show marked dwarﬁsm, which is ﬁrst detectable around weaning,
and die by the 5th–6th week of age. Thyroid and gonad development is also impaired in these animals.
Analysis of Six3+/−;Hesx1Cre/+ compound embryos indicates that hypopituitarism is the likely cause of these
defects since pituitary development is severely impaired in these mutants. Similar to the Hesx1-deﬁcient
embryos, Rathke's pouch is initially expanded in Six3+/−;Hesx1Cre/+ compound embryos due to an increase in
cell proliferation. Subsequently, the anterior pituitary gland appears bifurcated, dysmorphic and occasionally
ectopically misplaced in the nasopharyngeal cavity, but cell differentiation is unaffected. Our research has
revealed a role for Six3 in normal pituitary development, which has likely been conserved during evolution
as SIX3 is also expressed in the pituitary gland of the human embryo.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe pituitary gland is considered amaster regulator of homeostasis
in vertebrates as it regulates a multitude of vital physiological
functions such as metabolism, growth, fertility and stress response.
The mature pituitary gland is composed of three lobes; the anterior
and intermediate lobes (anterior pituitary, AP) and the posterior lobe
(posterior pituitary, PP), which arise from different embryonic tissues
(Cushman and Camper, 2001; Zhu et al., 2007). The anterior pituitary
forms early in mouse development at 8.5 days postcoitum (dpc)
through a thickening of the roof of the oral ectoderm (pituitary
placode) that contacts the ﬂoor of the ventral diencephalon. By
9.5 dpc, this thickened oral ectoderm tissue evaginates and forms
Rathke's pouch, the primordium of the AP. The mature AP houses six
hormone-producing cell types: corticotropes, thyrotropes, somato-
tropes, lactotropes, gonadotropes and melanotropes, which produce
adrenocorticotrophic hormone (ACTH), thyroid-stimulating hormone
(TSH), growth hormone (GH), prolactin (PRL), luteinising hormone
(LH) as well as follicle stimulating hormone (FSH), and melanocyte
stimulating hormone (MSH), respectively. Once secreted into the
blood stream, these hormones act upon their target organs (adrenal
glands, thyroid, bone, mammary glands, gonads and skin) to control. Martinez-Barbera).
l rights reserved.essential body functions. On the other hand, the PP is of neural origin
and arises from the infundibulum, a ventral evagination of the ﬂoor of
the diencephalon, which establishes intimate contact with Rathke's
pouch that is essential for normal development and function of the AP.
The PP is devoid of hormone-producing cells, but instead contains the
axonal projections from the hypothalamic nuclei, which produce the
hormones oxytosin (OT) and vasopressin (ADH). Unlike the AP, the PP
is highly innervated, but weakly vascularised. Failure to produce one
(usually Isolated Growth Hormone Deﬁciency, IGHD) or several of
these hormones (Combined Pituitary Hormone Deﬁciency, CPHD)
causes hypopituitarism in mice and humans (Procter et al., 1998;
Kelberman and Dattani, 2007).
HESX1 is a paired-like homeobox transcription factor that is
essential for normal forebrain and pituitary formation in both mice
and humans. Hesx1 expression is very dynamic and transcripts can be
detected transiently within the anterior forebrain from 7.5–8.5 dpc,
and in Rathke's pouch from 8.5–13.5 dpc (Thomas and Beddington,
1996; Hermesz et al., 1996). Hesx1−/− embryos exhibit variable degrees
of anterior forebrain defects, brought about by a cell fate transforma-
tion of anterior to posterior forebrain, possibly as a consequence of the
ectopic activation of the Wnt/β-catenin signalling pathway in the
anterior forebrain (Dattani et al., 1998; Martinez-Barbera et al., 2000;
Andoniadou et al., 2007). Hesx1−/− mutants develop dysmorphic
pituitaries, which are enlarged, bifurcated, and often misplaced in
the nasopharyngeal cavity. In spite of the very dramaticmorphological
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cell-type differentiation appears normal (Dasen et al., 2001; E. Sajedi
and J.P. Martinez-Barbera, unpublished). Hesx1−/− mice are not viable
and die perinatally (Dattani et al., 1998; Andoniadou et al., 2007).
Mutations in HESX1 have been associated with human phenotypes
affecting midline telencephalic commissural tracts (corpus callosum
and anterior commissure), the optic nerves and the pituitary gland,
such as septo-optic dysplasia (SOD) and CPHD (Kelberman and
Dattani, 2007).
SIX3 is a homeobox transcription factor related to the Drosophila
sine oculis gene (Oliver et al., 1995). Six3 and Hesx1 expression
domains partly overlap during early mouse development, in particular
within the anterior forebrain and Rathke's pouch. However, Six3
expression persists for longer in these tissues compared with Hesx1.
Targeted disruption of the Six3 locus has demonstrated the require-
ment for Six3 in normal forebrain formation (Lagutin et al., 2003). In
fact, Six3−/− embryos show forebrain defects, which are comparable to
those observed in Hesx1−/− mutants, although they are more severe
and fully penetrant. As in the Hesx1-deﬁcient embryos, there is a
posterior transformation of the anterior forebrain, which is likely to be
due to the activation of Wnt/β-catenin signalling in these cells.
Mutations in human SIX3 have been linked to holoprosencephaly
(Wallis et al., 1999). So far, it has not been possible to determine a role
for Six3 during pituitary development as the forebrain defects extend
to the region of the ventral diencephalon responsible for the initial
induction of Rathke's pouch.
The similarities between the Hesx1 and Six3 expression patterns,
and the common molecular mechanism underlying the forebrain
defects of targeted mutant mice for these genes, prompted us to
investigate the possibility that they might interact during normal
anterior forebrain and Rathke's pouch development. Interestingly, we
found that Six3+/−;Hesx1Cre/+ compound heterozygous animals exhibit
severe growth retardation after weaning, with additional gonadal and
thyroid gland defects, resulting in a lethal phenotype. We present
evidence that whilst the differentiation programme in the pituitary
gland occurs correctly, cell proliferation of AP progenitors is enhanced
at 12.5 dpc, which leads to hypertrophy and dysmorphogenesis of the
AP in Six3+/−;Hesx1Cre/+ compound embryos. Molecular analysis
suggests that this enhanced proliferation may be due to an up-
regulation of Wnt/β-catenin signalling in the pituitary gland in these
embryos. Our results demonstrate a novel role for Six3 in normal
pituitary morphogenesis.
Materials and methods
Mice
Hesx1Cre/+ mice carry a null allele in which the entire Hesx1 open
reading frame is replaced by the Cre recombinase coding sequence.
Hesx1Cre/Cre embryos show the same forebrain and pituitary defects to
those observed in Hesx1−/− embryos previously described (Dattani
et al., 1998; Martinez-Barbera et al., 2000; Andoniadou et al., 2007).
Hesx1Cre/+ mice were backcrossed to the C57BL6/J background for
approximately 6–7 generations. Six3+/− mice, originating on a CD1
background, were kindly provided by Dr. G. Oliver (Memphis, USA)
(Lagutin et al., 2003). We crossed Six3+/− founders with Hesx1Cre/+ to
generate Six3+/−;Hesx1Cre/+ mice. The growth study (Fig. 1) used
animals from this ﬁrst ﬁlial generation (F1). Animals were weighed
weekly fromweaning (3rd week) for four weeks to generate a growth
curve for each genotype. Subsequently, the colony was expanded
using Six3+/− stud males from F1, which were crossed to C57BL6/J
females. Therefore, although still on a mixed background, these Six3+/−
animals incorporated more C57BL6/J genetic background in subse-
quent generations. For the embryological studies, animals from the
ﬁrst 2–4 generations were used. It is worth mentioning that we have
observed an increase in the severity of the phenotype in subsequentgenerations, i.e. a proportion of double mutants die before weaning.
Therefore, as in the Hesx1-deﬁcient embryos (Andoniadou et al.,
2007), the genetic background has an effect on the phenotype of the
Six3+/−;Hesx1Cre/+ compound embryos. Genotyping of mice and
embryos was carried out by PCR on DNA puriﬁed from tail tip biopsies
from mice and embryos using speciﬁc primers (Lagutin et al., 2003;
Andoniadou et al., 2007). Primers and PCR protocols are available
upon request.
In situ hybridisation, histology, cell death and proliferation analyses
Preparation of mouse tissues and embryos, and in situ hybridisa-
tion on parafﬁn sections, were performed as described (Dasen et al.,
2001; Andoniadou et al., 2007). Cell death in the pituitary gland was
analysed by TUNEL staining on wax sections as described (Martinez-
Barbera et al., 2002). Proliferation analyses were performed using 6
alternate sagittal sections per embryo through the pituitary gland of at
least three embryos per genotype. The mitotic index of the luminal
cells represents the percentage of proliferating cells from the total
number of luminal cells (DAPI positive). Anti-phosphorylated-histone
H3 (1:1000) (rabbit polyclonal; Upstate) and anti-cyclin D2 (1:250)
(Rabbit anti-mouse; Autogen Bioclear) were used for these studies.
Quantitative real-time PCR
Total RNA was extracted from 12.5 dpc pituitary glands of wild-
type, Hesx1Cre/+, Hesx1Cre/Cre, Six3+/− and Six3+/−;Hesx1Cre/+ embryos
using the RNeasy Micro kit (Qiagen), including DNase I treatment.
Reverse transcription was performed using the Omniscript RT kit
(Qiagen) using random hexamers (Promega). Real-time qRT-PCR was
performed using the SYBRGreenER reagent (Invitrogen) on an Applied
Biosystems 7500 thermal cycler. The cycling steps were performed as
follows: one cycle of 50 °C for 2 min, one of 95 °C for 10 min, 40 cycles
of 95 °C for 15 s then 57 °C for 1 min. Reactions were run in triplicate
and repeated for several independent samples for each genotype
(n=3–6 for Hesx1, Lef1, Axin2, Pitx2, Cyclin D1, Cyclin D2 and c-Myc).
Fold changes in gene expression were determined using the ΔΔCT
method, using the 7500 Fast System software (Applied Biosystems),
by normalizing expression of targets to endogenous Gapdh. Data
values were presented as averages for each genotype and the standard
error of the mean (SEM) was calculated to determine the error bars
(±SEM). Forward and reverse primers used are shown in Supplemen-
tary Table S1.
Analysis of protein–protein interactions
Plasmids expressing GAL4-HESX1, SIX3-VP16 or TLE1-VP16 were
generated by cloning the speciﬁc coding regions into the pM and
pVP16 vectors (Clontech). A plasmid containing the entire mouse Six3
coding region was kindly provided by Dr. G. Oliver (Memphis, USA).
The plasmid expressing untagged HESX1 and the reporter plasmids p-
P3-luciferase and p-Gal4BS-luciferase have been previously described
(Sajedi et al., 2008). The integrity of the regions encoding the fusion
proteins was conﬁrmed by DNA sequencing. Cell transfection and
immunoprecipitation experiments were performed as described
(Sajedi et al., 2008).
Results
Growth retardation, hypoplasia of the thyroid gland and gonads and
premature lethality in Six3+/−;Hesx1Cre/+ compound mice
Intercrosses between Six3+/− and Hesx1Cre/+ animals produced
offspring that were phenotypically normal until weaning (3rd
postnatal week). Genotyping of embryos revealed the expected
Mendelian mode of inheritance for all genotypes, whereas there was
Fig. 1. Severe growth retardation and hypoplasia of the testis and thyroid gland in Six3+/−;Hesx1Cre/+ mice. (A) Six3+/−;Hesx1Cre/+ compound heterozygote showing growth retardation
and smaller body size compared with wild-type, Six3+/− and Hesx1Cre/+ littermates at four weeks of age. (B) Growth graphs of Six3+/−;Hesx1Cre/+ animals (crosses), wild-type (triangles),
Six3+/− (squares) or Hesx1Cre/+ (circles). Note the growth retardation and early lethality in Six3+/−;Hesx1Cre/+ animals when compared with other genotypes (pb0.001, one-way ANOVA).
(C, D) Transverse sections through the testis stained with hematoxylin–eosin of wild-type (C) and compound heterozygous (D) mice. Note that the Six3+/−;Hesx1Cre/+ testis has small
and hypocellular seminiferous tubules compared with the wild-type control (arrows in panels C, D). (E–H) Transverse sections through the thyroid gland stained with hematoxylin–
eosin of wild-type (E and G) and Six3+/−;Hesx1Cre/+ (F and H) animals. Note the abnormal histology in the Six3+/−;Hesx1Cre/+ animal, which shows an evident reduction in the number of
follicles, when compared with the wild-type (arrows). Photographs of histological analysis are representative of three embryos per genotype.
Table 1
Genotypes of embryos and mice from Six3+/− and Hesx1Cre/+ intercrosses
Stage Genotypes
+/+ Six3+/− Hesx1Cre/+ Six3+/−;Hesx1Cre/+
10.5 dpc 13 10 8 10
11.5 dpc 12 9 8 7
12.5 dpc 15 19 17 20
13.5 dpc 12 10 12 13
15.5 dpc 6 7 5 8
17.5 dpc 14 16 14 13
Total embryos (%) 72 (25.9%)a 71 (25.5%)a 64 (23%)a 71 (25.6%)a
3 weeks postnatal 22 21 22 17
8 weeks postnatal 22 21 22 3b
a Chi-square test showed no statistically signiﬁcant deviation from the expected 25%
ratios.
b The reduced survival of Six3+/−;Hesx1Cre/+ at 8 weeks is statistically signiﬁcant
(pb0.01, Z-test).
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(Table 1). Although this decrease was not statistically signiﬁcant, it is
notable that a small number of Six3+/−;Hesx1Cre/+micewere found dead
within the ﬁrst three weeks after birth (see Materials and methods).
Soon after weaning, it became evident that a large proportion (∼87%)
of Six3+/−;Hesx1Cre/+ mice failed to gain weight, resulting in animals
with severe growth retardation compared to the wild-type, Six3+/− or
Hesx1Cre/+ littermates (Fig. 1A). Both male (n=5) and female (n=6)
Six3+/−;Hesx1Cre/+ mice showed severe growth deﬁciency and
weighed around four times less than their Six3+/−, Hesx1Cre/+ or
wild-type littermates at ﬁve weeks of age. Eventually, these animals
died prematurely around the 5th–6th week of age (Fig. 1B).
Severe growth retardation resulting in dwarﬁsm has been
observed in mouse lines with compromised pituitary development
and function, such as in the Ames Dwarf (Prop1) and little (Ghrhr)
mouse mutants (Lin et al., 1993; Gage et al., 1995; Sornson et al., 1996)
and the Ghr (growth hormone receptor-deﬁcient embryos) and Cga
(αGsu subunit mutant) knockout mice (Kendall et al., 1995; Lupu et al.,
2001). Since Hesx1 has been implicated in hypopituitarism in mice
and humans (Dattani et al., 1998; Kelberman and Dattani, 2007) and
Six3 is reportedly expressed in the pituitary gland (Oliver et al.,
1995), we hypothesised that hypopituitarism could be responsible for
the growth impairment and perhaps the lethality in the Six3+/−;
Hesx1Cre/+ animals. To test this hypothesis we performed morpholo-
gical analyses on the testes and thyroid glands, two pituitary target
tissues (Kendall et al., 1995), in Six3+/−;Hesx1Cre/+ compound mice
compared with Six3+/−, Hesx1Cre/+ and wild-type littermates at
5 weeks postnatal. Histological analysis of Six3+/−;Hesx1Cre/+ com-
pound mice revealed the presence of small seminiferous tubules,which were hypocellular, and the absence of elongated spermatids
(Figs.1C, D; Supplementary Fig. S1). This phenotype has been observed
in mouse mutants manifesting deﬁcient secretion of the pituitary
hormones FSH and LH (Kendall et al., 1995; Kumar et al., 1997;
Nasonkin et al., 2004). Moreover, the thyroid gland showed a dramatic
reduction in the number of follicles on histological sections (Figs. 1E–
H). It has been shown that adequate pituitary input through the
secretion of TSH is essential for normal thyroid function (Kendall et al.,
1995; Nasonkin et al., 2004). Therefore, abnormal testicular and
thyroid morphology may suggest pituitary dysfunction. Since none of
these defects were observed in Six3+/−, Hesx1Cre/+ or wild-type
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two transcription factors during normal pituitary development and
that hypopituitarism is the most likely condition underlying the
growth retardation in Six3+/−;Hesx1Cre/+ double heterozygous mice.
Abnormal morphogenesis, but normal speciﬁcation and terminal
differentiation of the anterior pituitary in Six3+/−;Hesx1Cre/+ embryos
Hesx1−/− mutants show severe pituitary defects, which are evident
during embryogenesis (Dattani et al., 1998; Dasen et al., 2001). We
analysed the morphology and gene expression pattern of the
developing anterior pituitary in Six3+/−;Hesx1Cre/+ compound embryos
compared with unaffected littermates. A total of 31 Six3+/−;Hesx1Cre/+
compound embryos from 10.5–17.5 dpc were analysed.
In situ hybridisation at 13.5 dpc with Lhx3, a marker of the anterior
pituitary (Sheng et al., 1996), revealed two distinct phenotypes. SomeFig. 2. Abnormal morphology, but normal gene expression in Rathke's pouch in Six3+/−;Hesx
13.5 dpc embryos. Anterior is to the left. (A–E) Lhx3 is expressed in all genotypes, but note th
with single mutants (B, C) or wild-type littermates (A). The phenotype shown in panels D, I, N
panels E, J, O, T, Y was seen in the remaining three embryos. (F–O) The expression patterns
comparable among all genotypes. (P–T) Pomc1 expression in the ventral diencephalon (arrow
Six3+/−;Hesx1Cre/+ embryos in comparisonwith control embryos (P–R). (U–Y) Likewise, expres
not detected (Y) in double mutants compared with Six3+/− (V), Hesx1Cre/+ (W) or wild-type lembryos showed a dysmorphic anterior pituitary with a single lumen
(6/9 embryos) (Fig. 2D), whilst in others, the pouch was bifurcated,
had failed to separate from the oral ectoderm and exhibited multiple
lumens (3/9 embryos) (Fig. 2E). This latter phenotype may be the
consequence of a developmental delay in Rathke's pouch formation,
since there was no apparent variability in the morphology of the
pituitary gland at 15.5 dpc (6/6 embryos) (Fig. 3B). Morphological
abnormalities were not generally observed in wild-type, Six3+/− or
Hesx1Cre/+ embryos (Figs. 2A–C), although one Six3+/− embryo (n=17)
showed a slight abnormality in pituitary shape (data not shown).
Expression of several diagnostic pituitary and/or ventral dience-
phalic markers, including Prop1, Six3, Pomc1, Pit1, and Cga (Kendall
et al., 1995; Cohen et al., 1996; Dasen et al., 2001; Lamonet et al., 2004)
was essentially normal in Six3+/−;Hesx1Cre/+ compound embryos at
13.5–15.5 dpc, although the expression domains were enlarged and
the anterior pituitary was bifurcated in these mutants (Figs. 2F–Y and1Cre/+ embryos. In situ hybridisation on sagittal sections through the pituitary gland of
e abnormal morphology of Rathke's pouch in Six3+/−;Hesx1Cre/+ embryos (D, E) compared
, S, X was observed in 6/9 Six3+/−;Hesx1Cre/+ embryos, whilst the phenotype displayed in
of Prop1 (anterior pituitary) and Six3 (anterior pituitary and ventral diencephalon) are
in panel P) and anterior pituitary (arrowhead in panel P) is reduced (S) or absent (T) in
sion of Pit1 in the ventral region of the anterior pituitary is either down-regulated (X) or
ittermates (U).
Fig. 3. Normal anterior pituitary speciﬁcation in Six3+/−;Hesx1Cre/+ embryos at 15.5 dpc.
In situ hybridisation with Lhx3 (A, B), Pomc1 (C, D), Cga (encoding αGSU) (E, F) and Pit1
(G, H) in wild-type (+/+) and Six3+/−;Hesx1Cre/+ embryos. The expression domains are
expanded and the anterior pituitary appears hyperplastic in the double heterozygous
mutants.
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of Pomc1 and Pit1 expression in the hypothalamus (Pomc1; Figs. 2S, T)
and anterior pituitary (Pomc1 and Pit1; Figs. 2S, T, X, Y) in Six3+/−;
Hesx1Cre/+ compound embryos compared with other genotypes. A
similar delay in Pomc1 expression has been reported in mouse
embryos harbouring inactivatingHesx1mutations (Dasen et al., 2001).
NeuroD1 expression, which precedes that of Pomc1, was normal in
doublemutantswhen comparedwithwild-type littermates (Figs. 7I, J)
(Lamonet et al., 2004).
Analysis of embryos at 17.5 dpc showed that hormone-producing
cells were present in the anterior pituitary of the Six3+/−;Hesx1Cre/+
compound embryos, as evidenced by the expression of the terminal
differentiation markers Gh, Cga, Pomc1, Tshb, Prl, Lhb and Sf1 (Fig. 4).
The only signiﬁcant difference was the apparent reduction in Lhb-
expressing cell numbers, possibly reﬂecting a developmental delay in
the terminal differentiation of the gonadotrophs. Pre-gonadotroph
speciﬁcation was normal in compound embryos when compared
with wild-type littermates, evidenced by correct expression of Sf1, a
marker of pre-gonadotrophs. However, we observed two morpholo-
gically distinct phenotypes: (i) six Six3+/−;Hesx1Cre/+ compound
embryos showed pituitary glands normally located between the
hypothalamus and the basisphenoid bone (Figs. 4B, E, H, K, N, Q, T).
Morphologically, these were smaller along the medio-lateral axis but
expanded along the rostrocaudal axis. In two of the latter, pituitary
tissue could be seen invading the nasopharyngeal cavity (Supple-
mentary Fig. S2); (ii) three additional embryos appeared to have an
absent pituitary gland, as it could not be morphologically recognised
in its normal position in parafﬁn sections. However, in situ
hybridisation revealed the presence of a large mass of anterior
pituitary tissue ectopically located in the nasopharyngeal cavity (Figs.
4C, F, I, L, O, R). Taken together, these results suggest that there is no
major spatial or temporal disruption of the speciﬁcation or
differentiation programmes of the anterior pituitary in the Six3+/−;
Hesx1Cre/+ compound embryos, but morphogenesis was severely
impaired, occasionally resulting in misplacement of the pituitary
into the nasopharyngeal cavity. Ectopic pharyngeal pituitary has also
been reported in human embryos in association with craniofacial
defects (Kjaer and Hansen, 2000; Osman et al., 2006).
Finally, in situ hybridisation analysis of Six3+/−;Hesx1Cre/+ com-
poundmice at postnatal week four revealed the presence of all six cell
types, although the number of expressing cells appeared lower
compared with single heterozygous or wild-type animals (Fig. 5).
Increased cellular proliferation in Six3+/−;Hesx1Cre/+ compound embryos
It has been proposed that increased cellular proliferation and
recruitment of additional oral ectoderm into Rathke's pouch may
account for the observed enlargement and bifurcation of the anterior
pituitary in Hesx1−/− mutants (Dasen et al., 2001). Alternatively or in
addition, decreased cell death might also contribute to the observed
phenotype.Wedecided to analyse thecontributionof thesemechanisms
to the pituitary phenotype in Six3+/−;Hesx1Cre/+ compound embryos.
The initial induction of Rathke's pouch was assessed by in situ
hybridisation with Fgf8 and Lhx3 at 10.5 dpc. Fgf8 was expressed in
the ventral diencephalon in Six3+/−;Hesx1Cre/+ double heterozygotes
and no major differences were observed in these embryos compared
with Six3+/−, Hesx1Cre/+ and wild-type littermates (Supplementary Fig.
S3C, D). Likewise, no apparent differences were observed in Lhx3
expression in the developing Rathke's pouch (Supplementary Fig. S3A,
B). The expression pattern of Bmp4 was also comparable between
wild-type and Six3+/−;Hesx1Cre/+ mutants at 11.5 dpc (Supplementary
Fig. S3E, F). From this analysis, we conclude that the initial induction of
Rathke's pouch occurs normally in Six3+/−;Hesx1Cre/+ compound
embryos and that it is unlikely that the anterior pituitary hyperplasia
in these mutants is primarily caused by the recruitment of additional
oral ectoderm into Rathke's pouch at 10.5 dpc.Cell death was analysed by TUNEL staining on sections of the
pituitary at 12.5 dpc. The number of apoptotic cells within Rathke's
pouch and the developing anterior pituitary was almost negligible in
Six3+/−;Hesx1Cre/+ double heterozygotes, single mutants and wild-type
embryos (data not shown) (Ellworth et al., 2008). Therefore, decreased
cell death is unlikely to be an important contributor to the
enlargement and bifurcation of the developing pituitary gland in
double heterozygous embryos. Cell death was not affected in Hesx1-
deﬁcient embryos compared with wild-type littermates (data not
shown; Dasen et al., 2001).
Cellular proliferation was assessed at 11.5 and 12.5 dpc, when the
pituitary phenotype is ﬁrst detectable. At 11.5 dpc, more proliferating
cells were seen in the developing Rathke's pouch of the Six3+/−;
Hesx1Cre/+ compound embryos compared with other genotypes, but
differences were not statistically signiﬁcant (data not shown). In
contrast, at 12.5 dpc, it was evident that the anterior pituitary of the
Six3+/−;Hesx1Cre/+ mutants was hyperplastic (Fig. 6K). Likewise,
analysis of Hesx1Cre/Cre pituitaries at this stage revealed an increased
mitotic index in three mutants, correlating with mild forebrain
abnormalities, as previously suggested (n=5; Fig. 6K) (Dasen et al.,
2001). The remaining two mutants did not show an increase in
proliferation (data not shown). These mutants had signiﬁcant
forebrain and craniofacial defects, and an apparent developmental
delay in Rathke's pouch formation, i.e. Rathke's pouch remained
connected to the oral cavity and resembled that of an 11.5 dpc embryo
(Supplementary Fig. S4). It is important to emphasise that there is
no general developmental delay of Hesx1-deﬁcient embryos, but it
is only restricted to anterior forebrain structures, including the
Fig. 4. Normal terminal differentiation of hormone-producing cells in Six3+/−;Hesx1Cre/+ anterior pituitary glands. In situ hybridisation on transverse sections through the pituitary
glands of wild-type (A, D, G, J, M, P, S) and Six3+/−;Hesx1Cre/+ compound embryos showing either mild (B, E, H, K, N, Q, T) or severe (C, F, I, L, O, R, U) defects. In the mild phenotype, the
pituitary gland is positioned normally and all cell types are detectable. However, in severe cases, the pituitary gland is ectopicallymisplaced in the nasopharyngeal cavity (np inpanel C).
In general, all cell types are identiﬁable inSix3+/−;Hesx1Cre/+mutants, although Lhb expressionwas barely detectable inpanel O. This is likely to be as a consequence of delayeddifferentiation
of the gonadotrophs, as Sf1 expressionwas normal in the anterior pituitary (S–U). The apparent increase of signal in the hypothalamic area inpanel U is due to the axial level of the section.
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data, we conclude that the Six3+/−;Hesx1Cre/+ mutants phenocopy the
mild end of the spectrum of forebrain and pituitary defects observed
in Hesx1 null embryos.
Cell death and proliferation analyses were also performed at
17.5 dpc and at 30–33 days of age (postnatal week 4.5). Cell death, as
measured by TUNEL staining, was comparable between Six3+/−;
Hesx1Cre/+ mutants and wild-type littermates (data not shown).
However, cellular proliferation in the pituitary gland was signiﬁcantly
reduced in compound mutants (Supplementary Fig. S4). At 17.5 dpc,
the pituitary glands of Six3+/−;Hesx1Cre/+ mutants and wild-type
littermates were similar in size (although the mutant pituitary was
generally smaller). However, by 4.5 weeks postnatally, the wild-type
pituitary was much larger than that of compound mutants (Supple-
mentary Fig. S4). In fact, the latter appears similar in size to that of
17.5 dpc embryos.
Taken together, two main conclusions can be drawn from the
marker and proliferation analyses. First, the Hesx1/Six3 interaction
appears to be relevant for the normal control of proliferation in
periluminal progenitors of Rathke's pouch at 12.5 dpc. This is
consistent with previous results showing the involvement of these
two genes in the growth of the pituitary gland (Hesx1) and retina(Six3) and with the normal pattern of expression of these two genes
during pituitary development (Dasen et al., 2001; Dyer, 2003). Second,
the increased proliferation at early stages leads to an abnormal
morphogenesis of the pituitary gland in compound embryos without
affecting lineage speciﬁcation or ﬁnal differentiation at 17.5 dpc.
However, there is a knock-on effect in compound embryos that causes
a reduction in the proliferation rate of differentiated progenitors at
17.5 dpc and postnatally, possibly leading to hypopituitarism.
Increased proliferation might be mediated by up-regulation of the Wnt/
β-catenin pathway through LEF1–PITX2
Having established that increased proliferation is the primary
cellular defect responsible for the pituitary phenotype of the Six3+/−;
Hesx1Cre/+ compound embryos, we next sought a possible molecular
mechanism. Hesx1 and Six3 have been proposed to antagonise the
ectopic activation of the Wnt/β-catenin signalling pathway within the
anterior forebrain (Lagutin et al., 2003; Andoniadou et al., 2007).
Compelling evidence indicates that the Wnt/β-catenin signalling
pathway controls proliferation during normal development in a
variety of cell types, including the early pituitary (van Noort and
Clevers, 2002; Zhu and Rosenfeld, 2004; Arce et al., 2006; Hoppler and
Fig. 5. Hormone-producing cells are present in the postnatal pituitary gland of Six3+/−;
Hesx1Cre/+ animals. (A, B) Photographs of pituitary glands isolated fromwild-type (A) or
Six3+/−;Hesx1Cre/+ (B) mice at four weeks of age. (C–N) In situ hybridisation on transverse
sections through the pituitary glands shown in panels A, B. Note the speciﬁc signal in
Six3+/−;Hesx1Cre/+ sections with all the probes analysed, suggesting that hormone-
producing cells are still present at this stage.
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been shown to stimulate the expression of growth-regulating genes,
including Cyclin D1 (Ccnd1), Cyclin D2 (Ccnd2) and c-Myc (Kioussi
et al., 2002; Baek et al., 2003; Briata et al., 2003).We hypothesised that
over-activation of the Wnt/β-catenin signalling pathway might
contribute, at least in part, to the pituitary phenotype in the Six3+/−;
Hesx1Cre/+ compound embryos.
Firstly, we performed in situ hybridisation with several markers
that have been shown to act upon the Wnt/β-catenin signalling
pathway. SOX2 and SOX3, two inhibitory β-catenin partners that are
required for normal pituitary development (Figs. 7A–B; data not
shown) (Zorn et al., 1999; Rizzoti et al., 2004; Mansukhani et al., 2005;
Kelberman et al., 2006), were expressed normally in the ventral
diencephalon (Sox2 and Sox3) and developing Rathke's pouch (Sox2) in
Six3+/−;Hesx1Cre/+ compound embryos at 12.5 dpc (n=3). Likewise,
expression of Wnt4 (ventral diencephalon and pituitary) and Wnt5a(ventral diencephalon), was unaffected in Six3+/−;Hesx1Cre/+ compound
embryos compared with single heterozygous and wild-type embryos
(Figs. 7C–F; n=3) (Treier et al.,1998; Cha et al., 2004).We also analysed
the expression of knownWnt/β-catenin targets such as Lef1, Pitx2 and
Axin2. Axin2 is a known Wnt/β-catenin signalling target, which is
ectopically expressed within the anterior forebrain in both Hesx1−/−
(Jho et al., 2002; Andoniadou et al., 2007) and Six3−/− embryos (G.
Oliver, personal communication). Axin2 is normally expressed in a
high-ventral to low-dorsal gradient in the anterior pituitary at 12.5 dpc
(Olson et al., 2006) (Fig. 7G). In Six3+/−;Hesx1Cre/+ compound embryos
this characteristic gradient of expression was less evident and Axin2
transcripts were detected in more dorsal regions of the developing
anterior pituitary (Fig. 7H; n=4). Moreover, the hybridisation signal
appeared stronger in the anterior pituitary of the compound embryos
when compared with wild-type littermates. An apparent up-regula-
tion of Pitx2 expression in the developing pituitary of Six3+/−;Hesx1Cre/+
compound embryos compared with wild-type littermates was also
observed (Supplementary Fig. S3; n=3). However, in situ hybridisation
with Lef1 antisense riboprobes detected comparable low levels of
expression in the developing pituitary of compound embryos and
wild-type littermates at 12.5 dpc (data not shown). In conclusion, the
up-regulation of Axin2 and Pitx2 expression in the mutant Rathke's
pouch and developing anterior pituitary suggests that over-activation
of Wnt/β-catenin signalling might contribute to the pituitary hyper-
plasia observed in the double heterozygous mutants.
Next, quantitative real-time PCRwas used to analyse the expression
levels of some components of the Wnt/β-catenin–LEF1–PITX2 path-
way. Lef1, Pitx2 and Cyclin D2 expression levels were signiﬁcantly
higher in the pituitary gland of Six3+/;Hesx1Cre/+ compound embryos
compared with control pituitaries from other genotypes (Fig. 7M).
Immunostaining with a speciﬁc antibody against cyclin D2 revealed
the presence of higher numbers of cycling cells in the pituitary gland of
the double heterozygotes compared with wild-type littermates (Figs.
7K,L). Axin2 expression was elevated in Six3+/−;Hesx1Cre/+ and surpris-
ingly, in Six3+/− embryos, suggesting that Six3 haploinsufﬁciency alone
may cause up-regulation of Axin2, which may contribute to the mild
pituitary phenotype observed sporadically in Six3+/− embryos. This
analysis also revealed that Lef1 and Cyclin D2 expressionwas higher in
Hesx1Cre/Cre embryos compared with wild-type littermates, but Pitx2
andAxin2 expressionwas unaffected in thesemutants (Supplementary
Fig. S5). However, Cyclin D1 and c-Myc expression levels remained
unchanged in compoundheterozygotes comparedwith singlemutants
and wild-type embryos (data not shown). Two conclusions can be
drawn from these results: (i) Although the cellular consequences of
lacking either the twoHesx1 alleles inHesx1Cre/Cre embryos, or only one
of each in Six3+/−;Hesx1Cre/+ mutants are comparable (cellular hyper-
proliferation), there are molecular differences in the transcription
levels of particular Wnt/β-catenin components associated with
speciﬁc genotypes; (ii) The increased proliferation observed in
Six3+/−;Hesx1Cre/+ and Hesx1Cre/Cre embryos may be partly due to the
up-regulation of the Wnt/β-catenin/LEF1 pathway.
Molecular nature of the Hesx1/Six3 interaction
The possibility thatHesx1 is regulating Six3 expression appears to be
unlikely. Firstly, Six3 expression is normal in the pituitary of Hesx1-
deﬁcient embryos (Supplementary Fig. S3). Unfortunately, Six3−/−
embryos fail to form any pituitary tissue, which precludes the analysis
of Hesx1 expression. However, levels of Hesx1 mRNA in Six3+/− and
Six3+/+ (wild-type) pituitaries are comparable by qRT-PCR (Fig. 7M). This
does not support a regulatory role for Six3 on theHesx1 locus.Moreover,
within the anterior forebrain, Hesx1 is expressed in Six3−/− mutants and
Six3 is expressed in Hesx1−/− embryos. Taken together, the data suggest
that it is unlikely that Six3 and Hesx1 regulate each other.
We next explored whether the mechanism underlying the genetic
interaction between Hesx1 and Six3might be a direct protein–protein
Fig. 6. Increased cellular proliferation in the anterior pituitary of Six3+/−;Hesx1Cre/+ and Hesx1Cre/Cre embryos. (A–J) Fluorescent images of sections of 12.5 dpc embryos at the level of
the pituitary gland (anterior to the left) stained with either anti-phospho-histone H3 antibody (A–E) or DAPI (F–J). (K) Mitotic index of luminal cells in the anterior pituitary of
different genotypes. Six3+/−;Hesx1Cre/+ and Hesx1Cre/Cre have a signiﬁcantly higher mitotic index (pb0.001 one-way ANOVA) compared with wild-type, Six3+/− or Hesx1Cre/+ embryos.
Note the slight increase in the mitotic index in Six3+/− embryos, which failed to reach statistical signiﬁcance compared with wild-type.
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hybrid system. Co-transfection of CHO and 293T cells with plasmids
expressing either full-length HESX1 protein or a fusion of SIX3 to the
activation domain of the herpes simplex virus protein VP-16 (SIX3-
VP16) failed to reveal any signiﬁcant activation over the basal levels of
a luciferase reporter containing ﬁve copies of a consensus paired-like
binding site (P3) (Supplementary Fig. 6A). In contrast, co-expression of
HESX1 and TLE1-VP16 led to a signiﬁcant increase in luciferase
activity. TLE1 has been previously shown to interact with HESX1
(Dasen et al., 2001). Similar results were obtained when cells were
transfected with p-Gal4BS-luciferase reporter plasmid, which har-
bours GAL4 binding sites, and plasmids expressing GAL-4-HESX1 and
SIX3-VP16 fusion proteins (data not shown). Secondly, four attempts
to co-immunoprecipitate tagged HESX1 and SIX3 in mammalian cells
were unsuccessful, even though both proteins were expressed at high
levels and could be immunoprecipitated with speciﬁc anti-tag
antibodies (Supplementary Fig. S6B). Taken together with the fact
that a HESX1/SIX3 interaction has not been reported in several
screening studies aiming to identify HESX1 and SIX3 protein partners
(Zhu et al., 2002; Lopez-Rios et al., 2003; Sajedi et al., 2008), we
conclude that it is unlikely that HESX1 and SIX3 interact at the protein
level.
SIX3 is expressed in the pituitary gland of the human embryo
It has been previously reported that SIX3 is expressed in the eye of
the developing human embryo (Granadino et al., 1999), but it is
unknownwhether SIX3may also be expressed in the human pituitary
gland. To investigate this, we performed in situ hybridisation oncoronal parafﬁn sections through the developing anterior pituitary
and prospective hypothalamus of human embryos at Carnegie Stage
(CS) 17 and 20, and Fetal Stage (F) 1 (Fig. 8A). SIX3 expression was
detected in Rathke's pouch and overlying ventral diencephalon at CS
17 (Fig. 8A) and in the anterior and posterior lobes of the pituitary at
CS 20 (Fig. 8B). At F1, SIX3 expression was observed in the anterior
pituitary, and the ventricular zones of the hypothalamus and
telencephalic vesicles (Fig. 8C). This analysis indicates that SIX3
expression occurs during normal human pituitary gland embryogen-
esis, suggesting that its function in this organ may be conserved
between mice and humans.
Discussion
In this manuscript we show that haploinsufﬁciency of both Six3
and Hesx1 leads to severe pituitary dysmorphogenesis during
development, which results in hypopituitarism with dramatic post-
natal growth retardation of Six3+/−;Hesx1Cre/+ compound mice. This
research provides the ﬁrst evidence indicating an essential role for the
homeobox gene Six3 during normal pituitary formation.
Hesx1 and Six3 control cell proliferation of anterior pituitary progenitors
during development
Our data indicate that the primary cellular defect underlying the
anterior pituitary phenotype in Six3+/−;Hesx1Cre/+ compound embryos
is an increased proliferation of anterior pituitary progenitors between
11.5 and 12.5 dpc. This defect is also observed in a proportion of
Hesx1-deﬁcient (Hesx1Cre/Cre) embryos, suggesting that a similar
Fig. 7. Up-regulation of the β-catenin/LEF1–PITX2 pathway in Six3+/−;Hesx1Cre/+ pituitary glands. (A–J) In situ hybridisation on sagittal sections at the level of the pituitary gland of
12.5 dpc (A–F) and 13.5 dpc (G–J) wild-type and Six3+/−;Hesx1Cre/+ embryos. (A, B) Sox2 expression in the ventral diencephalon and infundibulum (arrows in panel A), and pituitary
gland (arrowhead, A) is similar between genotypes. (C, D) Wnt4 is expressed in the anterior pituitary gland of Six3+/−;Hesx1Cre/+ (D) and wild-type (C) embryos. (E, F) Wnt5a is
expressed in the ventral diencephalon and infundibulum of the double mutant (F) and wild-type (E) embryos. (G, H) Axin2 is expressed in a high-ventral to low-dorsal gradient
within the wild-type anterior pituitary (G). (H) Axin2 expression is increased in the ventral anterior pituitary of the Six3+/−;Hesx1Cre/+ embryo and appears to reach more dorsal levels
than in the wild-type littermate. (I, J) NeuroD expression is detected in the ventral side of the anterior pituitary in both genotypes. (K, L) Pituitary glands of 13.5 dpc wild-type (K) and
Six3+/−;Hesx1Cre/+ (L) embryos stained with an antibody against Cyclin D2. Note the increase of Cyclin D2-positive cells in themutant pituitary gland (L). (M) Quantitative real-time PCR
analysis of Hesx1, Lef1, Pitx2, Cyclin D2 and Axin2 expression in pituitary glands dissected fromwild-type (black bars), Hesx1Cre/+ (white bars), Six3+/− (grey bars) and Six3+/−;Hesx1Cre/+
(striped bars) embryos at 12.5 dpc. Note an up-regulation of Lef1 (pb0.005, one-way ANOVA) and Pitx2 (pb0.05, one-way ANOVA followed by Dunn's method) in Six3+/−;Hesx1Cre/+
compound embryos when compared with other genotypes. CyclinD2 is increased in double mutants (pb0.05, one-way ANOVA) in comparison with wild-type and Six3+/−, but not
compared with Hesx1Cre/+ embryos. Axin2 is up-regulated in Six3+/−;Hesx1Cre/+ double heterozygotes compared with wild-type and Hesx1Cre/+ embryos (pb0.05, one-way ANOVA).
Axin2 expression appears elevated in Six3+/− embryos compared with wild-type and Hesx1Cre/+, but the differences do not reach statistical signiﬁcance.
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mutants.
Normal pituitary growth is dependent on several signalling
pathways, including the FGF, TGFβ and Wnt/β-catenin pathways
(Treier et al., 1998; Ericson et al. 1998). Different lines of evidence
suggest that down-regulation of the Wnt/β-catenin signalling path-
way in anterior pituitary precursors during early stages of pituitary
development is required for normal pituitary formation. Firstly,
conditional removal of normal β-catenin function with a Pitx1-Cre
driver has no phenotypic consequences from 9.5 to 11.5 dpc,
suggesting that β-catenin does not play an essential role during
early pituitary development (Olson et al., 2006). Secondly, nuclearβ-catenin is not detected in the developing pituitary gland from 10.5
to 13.5 dpc (Brinkmeier et al., 2007). Thirdly, activation of Wnt/β-
catenin signalling through LEF1 has been proposed to induce Pitx2
expression, which in turn, controls the transcription of critical cell
cycle regulators that promote cell-type-speciﬁc proliferation (Kioussi
et al., 2002; Baek et al., 2003; Briata et al., 2003). Finally, whilst
mutations in Wnt4 are associated with pituitary hypoplasia (Treier
et al., 1998), embryos carrying a mutation in Tcf4, which usually acts
as a Wnt/β-catenin repressor (van Noort and Clevers, 2002; Arce et
al., 2006; Hoppler and Kavanagh, 2007), exhibit elevated cell
proliferation (Brinkmeier et al., 2007). In the forebrain, both Hesx1
and Six3 function to antagonise the activation of Wnt/β-catenin
Fig. 8. SIX3 is expressed in the developing pituitary of human embryos. In situ
hybridisation on coronal sections of human embryos at Carnegie Stages (CS) 17 and 20,
and at Fetal Stage 1 speciﬁed on the left side of the panel. (A) SIX3 is expressed in the
ventral diencephalon (arrows) and developing anterior pituitary (arrowhead) at CS17.
(B) Note the expression in the infundibulum (arrows) and anterior pituitary (arrow-
heads) at CS20. (C) At Fetal Stage 1 (F1), SIX3 transcripts are detected in the pituitary
gland (arrowhead) and in the ventricular zone of the hypothalamus (hy, inset) as well as
in the telencephalic vesicles (tv, inset). bs: basisphenoid cartilage.
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posterior cell fate transformation. Our data indicate that expression
of Lef1, Pitx2 and Cyclin D2 is elevated in both Six3+/−;Hesx1Cre/+ and
Hesx1Cre/Cre embryos and Axin2 (another Wnt/β-catenin target) is
expressed ectopically and at high levels in Six3+/−;Hesx1Cre/+ compound
heterozygotes compared with wild-type littermates. Therefore, it is
feasible that enhanced or ectopic Wnt/β-catenin signalling might be a
major contributor to the pituitary phenotype observed in the Six3+/−;
Hesx1Cre/+ compound and Hesx1Cre/Cre embryos. Although we cannot
exclude a role for the FGF and TGFβ signalling pathways, we have
shown that Fgf8 and Bmp4 expression is not grossly affected in either
Six3+/−;Hesx1Cre/+ or Hesx1-deﬁcient embryos compared with single
mutants or wild-type littermates at 10.5–11.5 dpc. It is worth noting
that the phenotypic consequences of enhancedWnt/β-catenin signal-
ling within the anterior forebrain (cell fate transformation) and
anterior pituitary progenitors (increased proliferation) are different,
supporting the idea that the speciﬁc response to a de-regulation of
Wnt/β-catenin signalling is highly context dependent (van Noort and
Clevers, 2002; Arce et al., 2006; Hoppler and Kavanagh, 2007).
The molecular basis of the genetic interaction between Hesx1 and
Six3 is not fully understood. We present data suggesting that a HESX1/
SIX3 protein–protein interaction is unlikely. Whether these two
transcription factors act in parallel pathways during pituitary
development or alternatively, they directly regulate transcription of
a subset of common genes, acting synergistically to regulate Wnt/β-
catenin signalling in the pituitary, is an important question that merits
further molecular studies.
Haploinsufﬁciency of Hesx1 and Six3 leads to hypopituitarism in mice
A puzzling aspect of the phenotype in the Six3+/−;Hesx1Cre/+
compound heterozygotes is that the pituitary gland is hyperplastic
during development but it becomes hypoplastic postnatally. More-
over, normal pituitary function is impaired as judged by the arrested
growth of the compoundmice and the histological defects observed in
pituitary target organs such as the thyroid and the testes. However, all
hormone-producing cell types are present in the pituitary gland of
Six3+/−;Hesx1Cre/+ compound mice. This observation can be partly
explained when considering that a proportion of anterior pituitary
tissue escapes from its normal location (between the hypothalamus
and basisphenoid bone) into the nasopharyngeal space. Although this
tissue contains hormone-producing cells, it is likely that its function
may be impaired as there is no contact with the hypothalamus, which
controls expression and secretion of anterior pituitary hormones.
Moreover, this ectopic tissue might be lost once the affected pups are
born, either by degeneration or by physical damage, as we have found
that it is often absent when the embryos are processed for histological
analysis. This is consistent with our observations that there is a
signiﬁcant reduction of pituitary tissue in Six3+/−;Hesx1Cre/+ compound
embryos at 17.5 dpc.
However, a signiﬁcant amount of anterior tissue remains in its
normal location in the compound mutants at 17.5 dpc. Our data
indicate that this remaining tissue fails to proliferate postnatally and
the pituitary gland of Six3+/−;Hesx1Cre/+ compound mice is very small
when compared with normal littermates. This suggests that the
hypothalamic–pituitary axis may be disrupted in these mutants, as it
has been shown that hypothalamic input through the hypophysio-
trophic factors is essential for normal postnatal expansion of
differentiated anterior hormone-producing cells (Billestrup et al.,
1986; Korbonits etal., 2004; Ward et al., 2005, 2006; Zhu et al., 2007).
Analysis of the Six3+/−;Hesx1Cre/+ compound mice (this study) and
other mouse models carrying inactivating Hesx1 mutations initially
identiﬁed in humans suffering from hypopituitarism and septo-optic
dysplasia (E.Sajedi and J.P. Martinez-Barbera, unpublished), suggests a
hypothalamic contribution to the pituitary phenotype in these mutant
mice.This is exempliﬁed by the fact that although developmentally, the
pituitary defects in Six3+/−;Hesx1Cre/+ embryos are very similar to those
described in embryos carrying these inactivating Hesx1 mutations
(Dasen et al., 2001; E.Sajedi and J.P. Martinez-Barbera, unpublished),
the phenotypic consequences in newborn mice are rather different.
The great majority of Hesx1−/− mice, which carry a null allele, die soon
after birth (Andoniadou et al., 2007). In contrast, newborns harbour-
ing a Hesx1 hypomorphic allele, in which there is a substitution of the
conserved isoleucine 26 by threonine, are generally viable and show
no growth defects (E. Sajedi and J.P. Martinez-Barbera, unpublished).
Finally, Six3+/−;Hesx1Cre/+ mice exhibit dwarﬁsm and die by the 5th–
6th week of age. It is important to emphasise that the main pheno-
typic difference between these genotypes is the presence of severe
forebrain defects in Hesx1−/− embryos, whereas both Hesx1I26T/I26T and
Six3+/−;Hesx1Cre/+mutants exhibit only mild forebrain defects (data not
shown). Since the pituitary defects are very similar between the three
genotypes, it is conceivable that there may be a neural contribution to
the growth retardation in Six3+/−;Hesx1Cre/+ compound mice. In fact,
Hesx1 is expressed in the prospective hypothalamic region between
8.5 and 9.5 dpc, and Six3 expression remains high in this area during
development until 16.5 dpc, making it feasible that a gene dosage
reduction of these two transcription factors could affect normal
diencephalic development, including the hypothalamus. Alternatively,
or in addition, defects in the portal blood system or impaired
connection between hypothalamus and anterior pituitary might
contribute to the postnatal hypopituitarism (Ward et al., 2006).
Although further research is needed to clarify the reasons underlying
332 C. Gaston-Massuet et al. / Developmental Biology 324 (2008) 322–333the postnatal phenotype of the Six3+/−;Hesx1Cre/+ compound mice, it is
interesting that conditional inactivation of Six3 either within the brain
or the pituitary gland leads to postnatal growth retardation and
premature death (A. Lavado and G. Oliver, personal communication),
implying that Six3 is required not only within the pituitary gland but
also in the forebrain for normal pituitary function.
It has been shown that dominant mutations in HESX1 associated
with human cases of hypopituitarism show a marked variability in
both the severity and penetrance of the phenotype (Dattani et al.,
1998; Kelberman and Dattani, 2007). Often, this variability is observed
between individuals carrying the same heterozygous mutationwithin
the same family, suggesting that factors other than the HESX1
genotype might be involved. Our research has revealed that whilst
single heterozygous individuals are normal, double heterozygous
Six3+/−;Hesx1Cre/+ animals exhibit hypopituitarism. This raises the
possibility that some of the HESX1 heterozygous human patients
might also be heterozygous for SIX3. The fact that SIX3 expression in
the developing pituitary gland is conserved in human embryos
supports this idea. Future research will evaluate the role of SIX3 in
the aetiology of these human conditions.
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